6-22382678-T-C
Variant names:
Variant summary
Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1
The ENST00000652081.2(CASC15):n.145+30027T>C variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.49 in 152,116 control chromosomes in the GnomAD database, including 18,394 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Genomes: 𝑓 0.49 ( 18394 hom., cov: 33)
Consequence
CASC15
ENST00000652081.2 intron
ENST00000652081.2 intron
Scores
2
Clinical Significance
Not reported in ClinVar
Conservation
PhyloP100: -1.59
Publications
2 publications found
Genes affected
CASC15 (HGNC:28245): (cancer susceptibility 15) This gene produces a long non-coding RNA that may regulate cell proliferation. This RNA is upregulated in hepatocellular carcinoma, where it is thought to function as an oncogene. However, some splice variants of this gene may function as a tumor suppressor in neuroblastoma and other tumor types. Circular RNA variants were observed at this gene. [provided by RefSeq, Dec 2017]
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -12 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.92).
BA1
GnomAd4 highest subpopulation (SAS) allele frequency at 95% confidence interval = 0.597 is higher than 0.05.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| LOC105374971 | XR_001744024.2 | n.368-17851T>C | intron_variant | Intron 2 of 4 |
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| CASC15 | ENST00000652081.2 | n.145+30027T>C | intron_variant | Intron 2 of 7 | ||||||
| CASC15 | ENST00000846434.1 | n.346+30027T>C | intron_variant | Intron 2 of 5 | ||||||
| CASC15 | ENST00000846435.1 | n.351+30027T>C | intron_variant | Intron 2 of 2 | ||||||
| CASC15 | ENST00000846436.1 | n.272-17908T>C | intron_variant | Intron 2 of 2 |
Frequencies
GnomAD3 genomes AF: 0.490 AC: 74487AN: 151998Hom.: 18362 Cov.: 33 show subpopulations
GnomAD3 genomes
AF:
AC:
74487
AN:
151998
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome AF: 0.490 AC: 74570AN: 152116Hom.: 18394 Cov.: 33 AF XY: 0.493 AC XY: 36668AN XY: 74364 show subpopulations
GnomAD4 genome
AF:
AC:
74570
AN:
152116
Hom.:
Cov.:
33
AF XY:
AC XY:
36668
AN XY:
74364
show subpopulations
African (AFR)
AF:
AC:
22087
AN:
41494
American (AMR)
AF:
AC:
7791
AN:
15266
Ashkenazi Jewish (ASJ)
AF:
AC:
1900
AN:
3468
East Asian (EAS)
AF:
AC:
2707
AN:
5172
South Asian (SAS)
AF:
AC:
2967
AN:
4820
European-Finnish (FIN)
AF:
AC:
5049
AN:
10596
Middle Eastern (MID)
AF:
AC:
121
AN:
294
European-Non Finnish (NFE)
AF:
AC:
30519
AN:
67988
Other (OTH)
AF:
AC:
986
AN:
2108
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
1992
3985
5977
7970
9962
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
676
1352
2028
2704
3380
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
2104
AN:
3478
ClinVar
Not reported inComputational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.